The U.S. Food and Drug Administration today approved Onglyza (saxagliptin), a once-daily tablet to treat Type 2 diabetes in adults. The medication is intended to be used with diet and exercise to control high blood sugar levels.
Read the complete post at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm174780.htm
Fri, Jul 31 2009 10:14 AM
Food and Drug Administration--Press Releases